Nothing Special   »   [go: up one dir, main page]

NO983828L - Imaging agents - Google Patents

Imaging agents

Info

Publication number
NO983828L
NO983828L NO983828A NO983828A NO983828L NO 983828 L NO983828 L NO 983828L NO 983828 A NO983828 A NO 983828A NO 983828 A NO983828 A NO 983828A NO 983828 L NO983828 L NO 983828L
Authority
NO
Norway
Prior art keywords
agent
imaging agents
contrast agent
regulator
effective amount
Prior art date
Application number
NO983828A
Other languages
Norwegian (no)
Other versions
NO983828D0 (en
Inventor
Natarajan Rajagopalan
Kevin Darryl Ostrander
Evan Gustow
Brian Doty
Philip Harnish
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO983828D0 publication Critical patent/NO983828D0/en
Publication of NO983828L publication Critical patent/NO983828L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0404—X-ray contrast preparations containing barium sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Oppfinnelsen frembringer et kontrastmiddel med gode dekkende egenskaper av den lavere mave/tarmkanal etter oral tilførsel. Midlet omfatter en diagnostisk effektiv mengde av et kontrastmiddel sammen med en viskositetsregulator og en osmotisk regulator, der nevnte regulatorer tilsammen er tilstede i en vektratio relativt nevnte middel på minst 1:20.The invention provides a contrast agent with good coverage properties of the lower gastrointestinal tract after oral administration. The agent comprises a diagnostically effective amount of a contrast agent together with a viscosity regulator and an osmotic regulator, wherein said regulators together are present in a weight ratio relative to said agent of at least 1:20.

NO983828A 1996-02-20 1998-08-20 Imaging agents NO983828L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603547.2A GB9603547D0 (en) 1996-02-20 1996-02-20 Contrast media
PCT/GB1997/000473 WO1997030736A2 (en) 1996-02-20 1997-02-20 Contrast medium

Publications (2)

Publication Number Publication Date
NO983828D0 NO983828D0 (en) 1998-08-20
NO983828L true NO983828L (en) 1998-10-15

Family

ID=10789076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983828A NO983828L (en) 1996-02-20 1998-08-20 Imaging agents

Country Status (11)

Country Link
EP (1) EP0881916A2 (en)
JP (1) JP2000504742A (en)
KR (1) KR19990087196A (en)
CN (1) CN1215342A (en)
AU (1) AU1885297A (en)
BR (1) BR9710946A (en)
CA (1) CA2247041A1 (en)
GB (1) GB9603547D0 (en)
HU (1) HUP9901323A2 (en)
NO (1) NO983828L (en)
WO (1) WO1997030736A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6928314B1 (en) 1998-01-23 2005-08-09 Mayo Foundation For Medical Education And Research System for two-dimensional and three-dimensional imaging of tubular structures in the human body
DE19844495B4 (en) * 1998-09-29 2005-04-07 Man Roland Druckmaschinen Ag Method for color calibration by means of color management for a digitally controllable printing press with a rewritable printing form
JP3461750B2 (en) 1999-03-04 2003-10-27 パナソニック コミュニケーションズ株式会社 Communication apparatus, communication method, and caller information registration method
US7591998B2 (en) 2000-03-07 2009-09-22 Kevin Tait Stool marker
AUPQ605500A0 (en) * 2000-03-07 2000-03-30 Medefield Pty Ltd Stool marker
US6477401B1 (en) 2000-03-10 2002-11-05 Mayo Foundation For Medical Education And Research Colonography of an unprepared colon
WO2007030132A2 (en) 2005-02-14 2007-03-15 Mayo Foundation For Medical Education And Research Electronic stool subtraction in ct colonography
US8043604B2 (en) 2007-04-27 2011-10-25 Pluromed, Inc. Ultrasonography using time- and temperature-sensitive variable adhesion coupling gels
CN108743976B (en) * 2013-03-15 2021-10-29 加利福尼亚大学董事会 Low-Z atom based intestinal CT contrast material
WO2015024025A1 (en) 2013-08-16 2015-02-19 The Regents Of The University Of California Silicone-based enteric ct contrast material
CN104587494A (en) * 2014-12-19 2015-05-06 张锐 Formula for barium meal for contrast of gastrointestinal tract and preparation method thereof
JP6491747B2 (en) 2015-09-30 2019-03-27 デューク・ユニヴァーシティ Contrast agent for magnetic resonance imaging
CN106075476B (en) * 2016-07-30 2019-05-31 温州市人民医院 A kind of contrast agent
US20210186819A1 (en) * 2018-09-07 2021-06-24 Moore Dental Technologies And Solutions Llc Dental Fracture Detection Compositions and Methods
CN109540936A (en) * 2019-01-11 2019-03-29 大连大学附属中山医院 It is a kind of for high-resolution ct and the room temperature contrast agent of x-ray artery, vein or pipeline and preparation method thereof
CN117503959B (en) * 2023-08-30 2024-07-09 吉锐威(北京)科技有限公司 Formula and preparation method of instant liquid oral gastric ultrasound developer based on magnesium aluminum silicate and microcrystalline cellulose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980001244A1 (en) * 1978-12-19 1980-06-26 Bykgulden Lomberg Chem Fab X-ray contrast media solutions
GB8916782D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5352459A (en) * 1992-12-16 1994-10-04 Sterling Winthrop Inc. Use of purified surface modifiers to prevent particle aggregation during sterilization
AU1816395A (en) * 1994-02-25 1995-09-11 Nycomed Imaging As X-ray contrast compositions containing cellulose derivatives

Also Published As

Publication number Publication date
WO1997030736A3 (en) 1997-12-18
EP0881916A2 (en) 1998-12-09
NO983828D0 (en) 1998-08-20
AU1885297A (en) 1997-09-10
JP2000504742A (en) 2000-04-18
CA2247041A1 (en) 1997-08-28
BR9710946A (en) 2000-10-31
CN1215342A (en) 1999-04-28
HUP9901323A2 (en) 1999-08-30
KR19990087196A (en) 1999-12-15
GB9603547D0 (en) 1996-04-17
WO1997030736A2 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
NO983828L (en) Imaging agents
ATE163042T1 (en) LACTOBACILLUS STRAINS OF HUMAN ORIGIN, THEIR COMPOSITION AND THEIR USE
BR9916132A (en) Compositions and their use
TR199802667T2 (en) Spiro-piperidine derivatives and their use as therapeutic agent.
PL316143A1 (en) Precursors of morpholinic tachykinin receptor antagonists
DZ2036A1 (en) N- (indole-2-carbonyl) -beta-alaninamides substituted and their derivatives, serving as anti-diabetic agents.
MY131774A (en) Coated pesticidal agents, processes for their preparation and compositions containing them
GB9410533D0 (en) In situ hybridisation and immuno-Chemical localisation of a growth factor
EE200100459A (en) A pharmaceutical agent in combination with a proton pump inhibitor or H2 receptor antagonist and a pharmaceutical composition containing them for use in the treatment of gastrointestinal disorders.
AU5313694A (en) Hair dye composition
MY119042A (en) Dolastatin derivatives, their preparation and use
EE200100458A (en) A pharmaceutical agent in combination with a proton pump inhibitor or H2 receptor antagonist and a pharmaceutical composition containing them for use in the treatment of gastrointestinal disorders.
ID26639A (en) PHARMACEUTICAL PROPERTIES THAT CONTAIN ANGIOTENSIN II RECEPTOR AGONISTS, TYPE 2 AND ITS USE
IE901821L (en) Porous pharmaceutical form
BG104916A (en) Calcilytic compounds
AU1667500A (en) N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthal necarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
NO974391L (en) Isolasjonsmörtel
HUP9700927A2 (en) Fluorinated vitamine d3 analogues and pharmaceutical compositions containing them
MX9707974A (en) 10, 13, 15 - trioxatricycle [9.2.1.1.9.6] - pentadecanone derivatives, procedures for their preparation, and medicaments containing these compounds.
PL316870A1 (en) Derivatives of 5-heterocyclo 1,5-benzodiazepine
RS49734B (en) Use of intravenous cotrast agents for projection mammography
IL107454A0 (en) Pharmaceutical compositions containing imidazol-1-yl compounds
FR2764602B1 (en) COSMETIC COMPOSITION COMPRISING AN AMIDE AND NEW AMIDES
MX9603199A (en) Endotheline receptors antagonists.
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions